Pandemic
New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1
Published in TB and Outbreaks Week, March 20th, 2007
GlaxoSmithKline (GSK) announces clinical trial data from two new studies, which show, for the first time, that GSK's candidate pre-pandemic split antigen H5N1 vaccine, formulated with GSK's proprietary adjuvant system, provides a substantial level of cross-immunity against a 'drifted' (diverse) strain of H5N1. It is hoped that the immune response elicited with this vaccine, could help prepare or 'prime' the immune system to rapidly respond against variants of the H5N1 strain and therefore protect the vaccinated population in the event of an H5N1 human pandemic.
In the first study presented at the IX International Symposium on Respiratory Viral Infections (ISRVI), data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bird Flu
Iowa Health Prediction Market Opens Trading On Avian Flu Market - Tuberculosis
UA researchers identify new adherence factor, Pili, produced by tuberculosis - Bioterrorism
Aethlon Medical Announces FDA Submission - Bird Flu
Bird Flu Booklet - 'What You Need to Know' - is Available from United Poultry Concerns in PDF and Printed Formats - Hepatitis E Virus
Study published in New England Journal of Medicine: Vaccine 95.5% effective against neglected hepatitis E - Legionnaire Disease
Infectious Disease, Legionella Experts Urge Hospitals to Reduce Infection and Protect Patients - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
